Publications by authors named "A Estival"

Claim this Profile
D
Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER Study.
Byoung Chul Cho, Myung-Ju Ahn, Makoto Nishio, Haruyasu Murakami, Dong Wan-Kim, Ana Estival

JTO Clin Res Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker landscape in advanced NSCLC: insights from a national prospective registry.
Mariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, Enric Carcereny, Virginia Calvo, Anna Estival

Lung Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New models for MPNST: establishment and comprehensive characterization of two tumor cell lines.
Sara Ortega-Bertran, Edgar Creus-Bachiller, Miriam Magallón-Lorenz, Meritxell Carrió, Bernat Gel, Anna Estival

Cancer Cell Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.
Antonio Calles, Mirian Alonso, Paloma Martín-Martorell, Ana Gómez, Javier de Castro, Anna Estival

Cancer Treat Res Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of heptacoordinated molybdenum(II) complexes supported with 2,6-bis(pyrazol-3-yl)pyridine (bpp) ligands.
Arno Estival, Luis E Blancarte, Loïc Pinto, Romane Pointis, Nathan Galas

Dalton Trans· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis